Predicting skin permeability from complex vehicles

Advanced Drug Delivery Reviews

Volumn 65, Issue 2, 2013, Pages 265-277

  Karadzovska, Daniela ^a   Brooks, James D ^a   Monteiro Riviere, Nancy A ^a   Riviere, Jim E ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Chemical mixtures; Formulations; Linear free energy relationships (LFER); Mixture factor; Percutaneous dermal absorption; QSAR; Quantitative structure permeation relationship (QSPR); Topical drug delivery enhancers

Indexed keywords

CHEMICAL MIXTURES; FORMULATIONS; LINEAR FREE ENERGY RELATIONSHIPS; QSAR; STRUCTURE-PERMEATION RELATIONSHIPS; TOPICAL DRUG DELIVERY ENHANCERS;

COMPUTATIONAL CHEMISTRY; DRUG DELIVERY; FORECASTING; FREE ENERGY; MIXTURES;

VEHICLES;

BETAMETHASONE DIPROPIONATE; COSMETIC; EMLA; HYDROCARBON; NANOPARTICLE; PENETRATION ENHANCING AGENT;

CHEMICAL INTERACTION; DERMIS; DRUG FORMULATION; ENVIRONMENTAL EXPOSURE; EPIDERMIS; EX VIVO STUDY; IN VITRO STUDY; OCCUPATIONAL EXPOSURE; PHYSICAL CHEMISTRY; PREDICTION; PRIORITY JOURNAL; REVIEW; SKIN ABSORPTION; SKIN PERMEABILITY; SKIN SURFACE; STRATUM CORNEUM; VALIDATION PROCESS;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; LINEAR ENERGY TRANSFER; MODELS, THEORETICAL; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; PHARMACEUTICAL VEHICLES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SKIN; SKIN ABSORPTION;

EID: 84873522106     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.01.019     Document Type: Review

References (184)

1. Bliss C.I. The toxicity of poisons applied jointly. Ann. Appl. Biol. 1939, 26:585-615.
2. Cross S.E., Pugh W.J., Hadgraft J., Roberts M.S. Probing the effect of vehicles on topical delivery: understanding the basic relationship between solvent and solute penetration using silicone membranes. Pharm. Res. 2001, 18:999-1005.
3. Idson B. Vehicle effects in percutaneous absorption. Drug Metab. Rev. 1983, 14:207-222.
4. Rosado C., Cross S.E., Pugh W.J., Roberts M.S., Hadgraft J. Effect of vehicle pretreatment on the flux, retention, and diffusion of topically applied penetrants in vitro. Pharm. Res. 2003, 20:1502-1507.
5. Sloan K.B., Koch S.A.M., Siver K.G., Flowers F.P. Use of solubility parameters of drug and vehicle to predict flux through skin. J. Invest. Dermatol. 1986, 87:244-252.
6. Nielsen J.B., Nielsen F. Dermal in vitro penetration of methiocarb, paclobutrazol, and pirimicarb. Occup. Environ. Med. 2000, 57:734-737.
7. Dias M., Naik A., Guy R.H., Hadgraft J., Lane M.E. In vivo infrared spectroscopy studies of alkanol effects on human skin. Eur. J. Pharm. Biopharm. 2008, 69:1171-1175.
8. Rosado C., Rodrigues L.M. Solvent effects in permeation assessed in vivo by skin surface biopsy. BMC Dermatol. 2003, 3:5.
9. Barry B.W. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 2001, 14:101-114.
10. Watkinson R.M., Herkenne C., Guy R.H., Hadgraft J., Oliveira G., Lane M.E. Influence of ethanol on the solubility, ionization and permeation characteristics of ibuprofen in silicone and human skin. Skin Pharmacol. Physiol. 2009, 22:15-21.
11. Watkinson R.M., Guy R.H., Hadgraft J., Lane M.E. Optimisation of cosolvent concentration for topical drug delivery on ibuprofen permeation. Skin Pharmacol. Physiol. 2009, 22:225-230.
12. Mills P.C., Magnusson B.M., Cross S.E. The effects of vehicle and region of application on in vitro penetration of testosterone through canine skin. Vet. J. 2006, 171:276-280.
13. Watkinson R.M., Guy R.H., Oliveira G., Hadgraft J., Lane M.E. Optimisation of cosolvent concentration for topical drug delivery III - influence of lipophilic vehicles on ibuprofen permeation. Skin Pharmacol. Physiol. 2011, 24:22-26.
14. Ita K.B., Di Preez J., Lane M.E., Hadgraft J., du Plessis J. Dermal delivery of selected hydrophilic drugs from elastic liposomes: effect of phospholipid formulation and choice of surfactants. J. Pharm. Pharmacol. 2007, 59:1215-1222.
15. Brand R.M., Mueller C. Transdermal penetration of atrazine, alachor and trifluralin: effect of formulation. Toxicol. Sci. 2002, 68:18-23.
16. Abou-Donia M.B., Wilmarth K.R., Jensen K.F., Oehme K.W., Kurt T.L. Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET and permethrin: implications of Gulf War chemical exposures. J. Toxicol. Environ. Health 1996, 48:35-56.
17. Baynes R.E., Xia X.R., Imran M., Riviere J.E. Quantification of chemical mixture interactions modulating dermal absorption using a multiple membrane fiber array. Chem. Res. Toxicol. 2008, 21:591-599.
18. Gregoire S., Ribaud C., Benech F., Meunier J.R., Garrigues-Mazert A., Guy R.H. Prediction of chemical absorption into and through the skin from cosmetic and dermatological formulations. Br. J. Dermatol. 2009, 160:80-91.
19. Barry B.W. Transdermal drug delivery. Aulton's Pharmaceutics, The Design and Manufacture of Medicines 2007, 580-585. Elsevier Churchill Livingstone, Edinburgh. third ed. M.E. Aulton (Ed.).
20. Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv. Drug Deliv. Rev. 2002, 54(Suppl. 1):S77-S98.
21. Riviere J.E. Chemical mixtures. Dermal Absorption Models in Toxicology and Pharmacology 2006, 283-303. CRC Press, Boca Raton. J.E. Riviere (Ed.).
22. Cappel M.J., Kreuter J. Effect on nonionic surfactants on transdermal drug delivery: I. Polysorbates. Int. J. Pharm. 1991, 69:143-153.
23. Ridout G., Hinz R.S., Hostynek J.J., Reddy A.K., Wiersema R.J., Hodson C.D., Lorence C.R., Guy R.H. The effects of zwitterionic surfactants on skin barrier function. Fundam. Appl. Toxicol. 1991, 16:41-50.
24. Ribaud C., Carson J.C., Doucet J., Leveque J.L. Organization of stratum corneum lipids in relation to permeability: influence of sodium lauryl sulfate and preheating. Pharm. Res. 1994, 11:1414-1418.
25. El Maghraby G.M., Williams A.C., Barry B.W. Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int. J. Pharm. 2004, 276:143-161.
26. Riviere J.E., Brooks J.D., Yeatts J.L., Koivisto E.L. Surfactant effects on skin absorption of model organic chemicals: implications for dermal risk assessment studies. J. Toxicol. Environ. Health A 2010, 73:725-737.
27. Williams A.C., Barry B.W. Penetration enhancers. Adv. Drug Deliv. Rev. 2004, 56:603-618.
28. Bach M., Lippold B.C. Percutaneous penetration enhancement and its quantification. Eur. J. Pharm. Biopharm. 1998, 46:1-13.
29. Guy R.H., Hadgraft J. Selection of drug candidates for transdermal drug delivery. Transdermal Drug Delivery 1989, 59-81. Marcel Dekker, New York. J. Hadgraft, R.H. Guy (Eds.).
30. Walters K.A. Penetration enhancers and their use in transdermal therapeutic systems. Transdermal Drug Delivery 1989, 197-246. Marcel Dekker, New York. J. Hadgraft, R.H. Guy (Eds.).
31. Goodman M., Barry B.W. Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique. J. Invest. Dermatol. 1988, 91:323-327.
32. Karande P., Jain A., Ergun K., Kispersky V., Mitragotri S. Design principles of chemical penetration enhancers for transdermal drug delivery. PNAS 2005, 102:4688-4693.
33. Karande P., Mitragotri S. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim. Biophys. Acta 2009, 1788:2362-2373.
34. Roberts M.S., Walker M. Water: the most natural penetration enhancer. Pharmaceuticsl Skin Penetration Enhancement 1993, 1-30. Marcel Dekker, New York. K. Walters, J. Hadgraft (Eds.).
35. Kaushik D., Batheija P., Kilfoyle B., Rai V., Michniak-Kohn B. Percutaneous permeation modifiers: enhancement versus retardation. Expert Opin. Drug Deliv. 2008, 5:517-529.
36. Kaushik D., Costache A., Michniak-Kohn B. Percutaneous penetration modifiers and formulation effects. Int. J. Pharm. 2010, 386:42-51.
37. Wotton P.K., Mollgaard B., Hadgraft J., Hoelgaard A. Vehicle effect on topical drug delivery. III. Effect of azone on the cutaneous permeation of metronidazole and propylene glycol. Int. J. Pharm. 1985, 24:19-26.
38. Trottet L., Merly C., Mirza M., Hadgraft J., Davis A.F. Effect of finite doses of propylene glycol on the enhancement of in vitro percutaneous permeation of loperamide hydrochloride. Int. J. Pharm. 2004, 274:213-219.
39. Otto A., Wiechers J.W., Kelly C.L., Hadgraft J., du Plessis J. Effect of penetration modifiers on the dermal and transdermal delivery of drugs and cosmetic active ingredients. Skin Pharmacol. Physiol. 2008, 21:326-334.
40. Surber C., Smith E. The vehicle: the pharmaceutical carrier of dermatological agents. Dermatopharmacology of Topical Preparations 2000, 5-21. Springer-Verlag, Berlin. B. Gabard, P. Elsner, C. Surber, P. Treffel (Eds.).
41. Cornell R.C., Stoughton R.B. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch. Dermatol. 1985, 121:63-67.
42. Bolzinger M.A., Briancon S., Chevalier Y. Nanoparticles through the skin: managing conflicting results of inorganic and organic particles in cosmetics and pharmaceutics. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2011, 3:463-478.
43. Borm P.J.A., Robbins D., Haubold S., Kuhlbusch T., Fissan H., Donaldson K., Schins R., Stone V., Keyling W., Lademann J., Krutmann J., Warheit D., Oberdorster E. The potential risk of nanomaterials: a review carried out for ECETOC. Part. Fibre Toxicol. 2006, 3:11.
44. Alvarez-Roman R., Naik A., Kalia Y.N., Guy R.H., Fessi H. Skin penetration and distribution of polymeric nanoparticles. J. Control. Release 2004, 99:53-62.
45. Prow T.W., Grice J.E., Lin L.L., Faye R., Butler M., Becker W., Wurm E.M.T., Yoong C., Robertson T.A., Soyer H.P., Roberts M.S. Nanoparticles and microparticles for skin drug delivery. Adv. Drug Deliv. Rev. 2011, 63:470-491.
46. Alvarez-Roman R., Barre G., Guy R.H., Fessi H. Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. Eur. J. Pharm. Biopharm. 2001, 52:191-195.
47. Jenning V., Gysler A., Schafer-Korting M., Gohla S.H. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur. J. Pharm. Biopharm. 2000, 49:211-218.
48. Miyazaki S., Takahashi A., Kubo W., Bachynysky J., Loebenberg R. Poly N-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. J. Pharm. Pharm. Sci. 2003, 6:238-245.
49. Luengo J., Weiss B., Schneider M., Ehlers A., Stracke F., Konig K., Kosta K.H., Lehr C.M., Schaefer U.F. Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol. Physiol. 2006, 19:190-197.
50. Wu X., Biatry B., Cazeuve C., Guy R.H. Drug delivery to the skin from sub-micron polymeric particle formulations: influence of particle size and polymer hydrophobicity. Pharm. Res. 2009, 26:1995-2001.
51. Wu X., Price G.J., Guy R.H. Disposition of nanoparticles and an associated lipophilic permeant following topical application to the skin. Mol. Pharm. 2009, 6:1441-1448.
52. Wu X., Landfester K., Musyanovych A., Guy R.H. Disposition of charged nanoparticles after their topical application to the skin. Skin Pharmacol. Physiol. 2010, 23:117-123.
53. FAQs: Nanotechnology, National Nanotechnology Initiative 2010.
54. Riviere J.E., Monteiro-Riviere N.A. Dermal exposure and absorption of chemicals and nanomaterials. Comprehensive Toxicology 2010, 111-122. Academic Press, Oxford. C.A. McQueen (Ed.).
55. Baroli B. Penetration of nanoparticles and nanomaterials in skin: fiction or reality?. J. Pharm. Sci. 2010, 99:21-50.
56. Schneider M., Stracke F., Hansen S., Schaefer U.F. Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinology 2009, 1:197-206.
57. Monteiro-Riviere N.A., Riviere J.E. Interaction of nanomaterials with skin: aspects of absorption and biodistribution. Nanotoxicology 2009, 3:188-193.
58. Monteiro-Riviere N.A., Baroli B. Nanomaterial penetration. Toxicology of the Skin: Target Organ Series 2010, 333-346. Informa Healthcare USA, Inc., New York. N.A. Monteiro-Riviere (Ed.).
59. Monteiro-Riviere N.A., Inman A.O., Ryman-Rasmussen J.P. Dermal effects of nanomaterials. Nanotoxicology: Characterization, Dosing and Health Effects 2007, 317-337. Informa Healthcare USA, Inc, New York. N.A. Monteiro-Riviere, C.L. Tran (Eds.).
60. Lademann J., Patzelt A., Richter H., Antoniou C., Sterry W., Knorr F. Determination of the cuticula thickness of human and porcine hairs and their potential influence on the penetration of nanoparticles into the hair follicles. J. Biomed. Opt. 2009, 14:021014.
61. Lademann J., Richter H., Schaefer U.F., Blume-Peytavi U., Teichmann A., Otberg N., Sterry W. Hair follicles - a long-term reservoir for drug delivery. Skin Pharmacol. Physiol. 2006, 19:232-236.
62. Lademann J., Richter H., Teichmann A., Otberg N., Blume-peytavi U., Luengo J., Weiss B., Schaefer U.F., Lehr C.M., Wepf R., Sterry W. Nanoparticles - an efficient carrier for drug delivery into the hair follicles. Eur. J. Pharm. Biopharm. 2007, 66:159-164.
63. Scheuplein R.J., Blank I.H. Permeability of the skin. Physiol. Rev. 1971, 51:702-747.
64. OECD Guidelines for the testing of chemicals Section4: Health Effects Test No. 428 Skin Absorption: In Vitro Method 2004, OECD, Paris.
65. Monteiro-Riviere N.A. Structure and function of skin. Toxicology of the Skin: Target Organ Series 2010, 1-18. Informa Healthcare USA, Inc., New York. N.A. Monteiro-Riviere (Ed.).
66. Monteiro-Riviere N.A. Comparative anatomy, physiology and biochemistry of mammalian skin. Dermal and Ocular Fundamentals and Methods 1991, 3-71. CRC Press, Boca Raton. D.W. Hobson (Ed.).
67. Monteiro-Riviere N.A., Baynes R.E., Riviere J.E. Animal skin morphology and dermal absorption. Dermal Absorption and Toxicity Assessment 2008, 17-35. Informa Healthcare USA, Inc. second ed. M.S. Roberts, K.A. Walters (Eds.).
68. Roberts M.S., Gierden A., Riviere J.E., Monteiro-Riviere N.A. Solvent and vehicle effects on the skin. Dermal Absorption and Toxicity Assessment 2007, 433-447. Informa Healthcare USA, Inc., New York. second ed. M.S. Roberts, K.A. Walters (Eds.).
69. Monteiro-Riviere N.A. Anatomical factors that affect barrier function. Marzulli and Maibach's Dermatotoxicology 2007, 39-50. CRC Press, New York. seventh ed. H. Zhai, K.P. Wilhelm, H.I. Maibach (Eds.).
70. Elias P.M. Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 1983, 80(Suppl):44s-49s.
71. Roberts M., Cross S., Pellet M. Skin transport. Dermatological and Transdermal Formulations 2002, 89-195. Marcel Dekker, New York. K.A. Walters (Ed.).
72. Ghafourian T., Samaras E.G., Brooks J.D., Riviere J.E. Modelling the effect of mixture components on permeation through skin. Int. J. Pharm. 2010, 398:28-32.
73. Kai T., Mak V.H.W., Potts R.O., Guy R.H. Mechanisms of percutaneous penetration enhancement: effect of n-alkanols on the permeability barrier of hairless mouse skin. J. Control. Release 1990, 12:103-112.
74. Raykar P.V., Fung M.C., Anderson B.D. The role of protein and lipid domains in the uptake of solutes by human stratum corneum. Pharm. Res. 1988, 5:140-150.
75. Forster M., Bolzinger M.A., Fessi H., Briancon S. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery. Eur. J. Dermatol. 2009, 19:309-323.
76. Michaels A.S., Chandrasekaran S.K., Shaw J.E. Drug permeation through human skin: theory and in vitro experimental measurements. AIChE J. 1975, 21:985-996.
77. Elias P.M., Cooper E.R., Korc A., Brown B.E. Percutaneous transport in relation to stratum corneum structure and lipid composition. J. Invest. Dermatol. 1981, 76:297-301.
78. Albery W.J., Hadgraft J. Percutaneous absorption: in vivo experiments. J. Pharm. Pharmacol. 1979, 31:140-147.
79. Van der Merwe D., Riviere J.E. Comparative studies on the effects of water, ethanol and water/ethanol mixtures on chemical partitioning into porcine stratum corneum and silastic membrane. Toxicol. In Vitro 2005, 19:69-77.
80. Swartzendruber D.C., Wertz P.W., Kitko D.J., Madison K.C., Downing D.T. Molecular models of the intercellular lipid lamellae in mammalian stratum corneum. J. Invest. Dermatol. 1989, 92:251-257.
81. Forslind B. A domain mosaic model of the skin barrier. Acta Derm. Venereol. 1994, 74:1-6.
82. Norlen L. Molecular skin barrier models and some central problems for the understanding of skin barrier structure and function. Skin Pharmacol. Appl. Skin Physiol. 2003, 16:203-211.
83. Bouwstra J.A., Honeywell-Nguyen P.L., Gooris G.S., Ponec M. Structure of the skin barrier and its modulation by vesicular formulations. Prog. Lipid Res. 2003, 42:1-36.
84. Norlen L. Skin barrier and function: the single gel-phase model. J. Invest. Dermatol. 2001, 117:830-836.
85. Guy R.H., Hadgraft J. Physicochemical aspects of percutaneous penetration and its enhancement. Pharm. Res. 1988, 5:753-758.
86. Katz M. Design of topical drug products: pharmaceutics. Drug Design 1973, 93-148. Academic Press, New York. E.J. Ariens (Ed.).
87. Williams A.C., Barry B.W. Chemical penetration enhancement. Dermal Absorption and Toxicity Assessments 1998, 297-312. Marcel Dekker, New York. M.S. Roberts, K.A. Walters (Eds.).
88. Moser K., Kriwet K., Kalia Y.N., Guy R.H. Enhanced skin permeation of a lipophilic drug using supersaturated formulations. J. Control. Release 2001, 73:245-253.
89. Monteiro-Riviere N.A., Inman A.O., Mak V., Werts P., Riviere J.E. Effect of selective lipid extraction from different body regions on epidermal barrier function. Pharm. Res. 2001, 18:992-998.
90. Rastogi S.K., Singh J. Lipid extraction and transport of hydrophilic solutes through porcine epidermis. Int. J. Pharm. 2001, 225:75-82.
91. Bronaugh R.L., Stewart R.F., Storm J.E. Extent of cutaneous metabolism during percutaneous absorption of xenobiotics. Toxicol. Appl. Pharmacol. 1989, 99:534-543.
92. Mukhtar H. Pharmacology of the Skin 1992, CRC Press, Boca Raton.
93. Elias P.M., Feingold K.R. Lipids and the epidermal water barrier: metabolism, regulation, and pathophysiology. Semin. Dermatol. 1992, 11:176-182.
94. Allen D.G., Riviere J.E., Monteiro-Riviere N.A. Induction of early biomarkers of inflammation produced by keratinocytes exposed to jet fuels Jet A, JP-8, and JP-8(100). J. Biochem. Mol. Toxicol. 2000, 14:231-237.
95. Luger T.A., Schwarz T. Evidence for an epidermal cytokine network. J. Invest. Dermatol. 1990, 95:100S-104S.
96. Monteiro-Riviere N.A., Baynes R.E., Riviere J.E. Pyridostigmine bromide modulates topical irritant-induced cytokine release from human epidermal keratinocytes and isolated perfused porcine skin. Toxicology 2003, 183:15-28.
97. Morgan E.T. Regulation of cytochrome P450 by inflammatory mediators: why and how?. Drug Metab. Dispos. 2001, 29:207-212.
98. Riviere J.E., Williams P.L. Pharmacokinetic implications of changing blood flow in skin. J. Pharm. Sci. 1992, 81:601-602.
99. Williams P.L., Riviere J.E. Model describing transdermal iontophoretic delivery of lidocaine incorporating consideration of cutaneous microvascular state. J. Pharm. Sci. 1993, 82:1080-1084.
100. Riviere J.E., Monteiro-Riviere N.A. The isolated porcine skin flap as an in vitro model for percutaneous absorption and cutaneous toxicology. Crit. Rev. Toxicol. 1991, 21:329-344.
101. Bronaugh R.L., Stewart R.F. Methods for in vitro percutaneous absorption studies IV: the flow-through diffusion cell. J. Pharm. Sci. 1985, 74:64-67.
102. Xia X.R., Baynes R.E., Riviere J.E. A novel system coefficient approach for systematic assessment of dermal absorption from chemical mixtures. Dermal Absorption Models in Toxicology and Pharmacology 2006, 71-88. CRC Press, Boca Raton. J.E. Riviere (Ed.).
103. Franz T.J. Percutaneous absorption on the relevance of in vitro data. J. Invest. Dermatol. 1975, 64:190-195.
104. Addicks W.J., Flynn G.L., Weiner N. Validation of a flow through diffusion cell for use in transdermal research. Pharm. Res. 1987, 4:337-341.
105. Monteiro-Riviere N.A. Specialized technique: the isolated perfused porcine skin flap (IPPSF). Methods for Skin Absorption 1990, 176-189. CRC Press, Boca Raton. B.W. Kemppainen, W.G. Reifenrath (Eds.).
106. Xia X.R., Baynes R.E., Monteiro-Riviere N.A., Leidy R.B., Shea D., Riviere J.E. A novel in-vitro technique for studying percutaneous permeation with a membrane-coated fiber and gas chromatography/mass spectrometry: part I. Performances of the technique and determination of the permeation rates and partition coefficients of chemical mixtures. Pharm. Res. 2003, 20:275-282.
107. Riviere J.E., Baynes R.E., Xia X.R. Membrane-coated fiber array approach for predicting skin permeability of chemical mixtures from different vehicles. Toxicol. Sci. 2007, 99:153-161.
108. Xia X.R., Baynes R.E., Monteiro-Riviere N.A., Riviere J.E. An experimentally based approach for predicting skin permeability of chemicals and drugs using membrane-coated fiber array. Toxicol. Appl. Pharmacol. 2007, 221:320-328.
109. Xia X.R., Baynes R.E., Monteiro-Riviere N.A., Riviere J.E. A system coefficient approach for quantitative assessment of the solvent effects on membrane absorption from chemical mixtures. SAR QSAR Environ. Res. 2007, 18:579-593.
110. Feldstein M.M., Raigorodskii I.M., Iordanskii A.L., Hadgraft J. Modeling of percutaneous drug transport in vitro using skin-imitating Carbosil membrane. J. Control. Release 1998, 52:25-40.
111. Agatonovic-Kustrin S., Beresford R., Yusof A.P.M. ANN modelling of the penetration across a polydimethylsiloxane membrane from theoretically derived molecular descriptors. J. Pharm. Biomed. Anal. 2001, 26:241-254.
112. Garrett E.R., Chemburkar P.B. Evaluation, control, and prediction of drug diffusion through polymeric membrane. I. Methods and reproducibility of steady-state diffusion studies. J. Pharm. Sci. 1968, 57:944-948.
113. Baynes R.E., Brooks J.D., Riviere J.E. Membrane transport of naphthalene and dodecane in jet fuel mixtures. Toxicol. Ind. Health 2000, 16:225-238.
114. Flynn G.L., Yalkowsky S.H. Correlation and prediction of mass transport across membrane. I. Influence of alkyl chain length on flux-determining properties of barrier and diffusant. J. Pharm. Sci. 1972, 61:838-852.
115. Riviere J.E. Dermal chemical mixtures. Principles and Practice of Mixtures Toxicology 2010, 349-376. Wiley-VCH, Hoboken. M. Mumtaz (Ed.).
116. Van der Merwe D., Riviere J.E. Effect of vehicles and surfactants, on xenobiotic permeability and stratum corneum partitioning in porcine skin. Toxicology 2005, 206:325-335.
117. Ostrenga J., Steinmetz C., Poulsen C. Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy. J. Pharm. Sci. 1971, 60:1175-1179.
118. Aungst B.J., Blake J.A., Hussain M.A. Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm. Res. 1990, 7:712-718.
119. Finnin B.C., Morgan T.M. Transdermal penetration enhancers: applications, limitations, and potential. J. Pharm. Sci. 1999, 88:955-958.
120. Scheuplein R.J., Blank I.H. Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. J. Invest. Dermatol. 1973, 60:286-296.
121. Hadgraft J. Recent developments in topical and transdermal delivery. Eur. J. Drug Metab. Pharmacokinet. 1996, 21:165-173.
122. Trommer H., Neubert R.H. Overcoming the stratum corneum: the modulation of skin penetration - a review. Skin Pharmacol. Physiol. 2006, 19:106-121.
123. Chrit L., Bastien P., Sockalingum G., Batisse D., Leroy F., Manfait M., Hadjur C. An in vivo randomized study of human skin moisturization by a new confocal Raman fiber-optic microprobe: assessment of a glycerol-based hydration cream. Skin Pharmacol. Physiol. 2006, 19:207-215.
124. Traynor M.J., Wilkinson S.C., Williams F.M. The influence of water mixtures on the dermal absorption of glycol ethers. Toxicol. Appl. Pharmacol. 2007, 218:128-134.
125. Baynes R.E., Brooks J.D., Mumtaz M., Riviere J.E. Effect of chemical interactions in pentachlorophenol mixtures on skin and membrane transport. Toxicol. Sci. 2002, 69:295-305.
126. Shokri J., Nokhodchi A., Dashbolaghi A., Hassan-Zadeh D., Ghafourian T., Barzegar Jalali M. The effect of surfactants on the skin penetration of diazepam. Int. J. Pharm. 2001, 228:99-107.
127. Riviere J.E., Qiao G., Baynes R.E., Brooks J.D., Mumtaz M. Mixture component effects on the in vitro dermal absorption of pentachlorophenol. Arch. Toxicol. 2001, 75:329-334.
128. Qiao G.L., Brooks J.D., Baynes R.E., Monteiro-Riviere N.A., Williams P.L., Riviere J.E. The use of mechanistically defined chemical mixtures (MDCM) to assess component effects on the percutaneous absorption and cutaneous disposition of topically exposed chemicals. I. Studies with parathion mixtures in isolated perfused porcine skin. Toxicol. Appl. Pharmacol. 1996, 141:473-486.
129. Baynes R.E., Brownie C., Freeman H., Riviere J.E. In vitro percutaneous absorption of benzidine in complex mechanistically defined chemical mixtures. Toxicol. Appl. Pharmacol. 1996, 141:497-506.
130. Williams P.L., Thompson D., Qiao G.L., Monteiro-Riviere N.A., Baynes R.E., Riviere J.E. The use of mechanistically defined chemical mixtures (MDCM) to assess component effects on the percutaneous absorption and cutaneous disposition of topically exposed chemicals. II. Development of a general dermatopharmacokinetic model for the use in risk assessment. Toxicol. Appl. Pharmacol. 1996, 141:487-496.
131. Budsaba K., Smith C.E., Riviere J.E. Compass plots: a combination of star plot and analysis of means to visualize significant interactions in complex toxicology studies. Toxicol. Methods 2000, 10:313-332.
132. Kim Y.C., Ludovice P.J., Prausnitz M.R. Transdermal delivery enhanced by magainin pore-forming peptide. J. Control. Release 2007, 122:375-383.
133. 14C] permethrin. Toxicol. Appl. Pharmacol. 2002, 181:164-173.
134. 14C-permethrin. Toxicol. Lett. 2002, 135:61-71.
135. Beall H.D., Sloan K.B. Topical delivery of 5-fluorouracil (5-Fu) by 3-alkylcarbonyl-5-Fu prodrugs. Int. J. Pharm. 2001, 217:127-137.
136. Beall H.D., Sloan K.B. Topical delivery of 5-fluorouracil (5-FU) by 1,3-bisalkylcarbonyl-5-FU prodrugs. Int. J. Pharm. 2002, 231:43-49.
137. Megwa S.A., Cross S.E., Whitehouse M.W., Benson H.A., Roberts M.S. Effect of ion pairing with alkylamines on the in-vitro dermal penetration and local tissue disposition of salicylates. J. Pharm. Pharmacol. 2000, 52:929-940.
138. Megwa S.A., Cross S.E., Benson H.A., Roberts M.S. Ion-pair formation as a strategy to enhance topical delivery of salicylic acid. J. Pharm. Pharmacol. 2000, 52:919-928.
139. Sarveiya V., Templeton J.F., Benson H.A. Ion-pairs of ibuprofen: increased membrane diffusion. J. Pharm. Pharmacol. 2004, 56:717-724.
140. Ehrenstrom Reiz G.M., Reiz S.L. EMLA - a eutectic mixture of local anaesthetics for topical anaesthesia. Acta Anaesthesiol. Scand. 1982, 26:596-598.
141. Heuschkel S., Goebel A., Neubert R.H. Microemulsions - modern colloidal carrier for dermal and transdermal drug delivery. J. Pharm. Sci. 2008, 97:603-631.
142. Kogan A., Garti N. Microemulsions as transdermal drug delivery vehicles. Adv. Colloid Interface Sci. 2006, 123-126:369-385.
143. Delgado-Charro M.B., Iglesias-Vilas G., Blanco-Mendez J., Lopez-Quineta M.A., Marty J.P., Guy R.H. Delivery of a hydrophilic solute through the skin from novel microemulsion systems. Eur. J. Pharm. Biopharm. 1997, 43:37-42.
144. Kreilgaard M., Pedersen E.J., Jaroszewski J.W. NMR characterization and transdermal drug delivery potential of microemulsion systems. J. Control. Release 2000, 69:421-433.
145. Santos P., Watkinson A.C., Hadgraft J., Lane M.E. Application of microemulsion in dermal and transdermal drug delivery. Skin Pharmacol. Physiol. 2008, 21:246-259.
146. El Maghraby G.M., Barry B.W., Williams A.C. Liposomes and skin: from drug delivery to model membranes. Eur. J. Pharm. Sci. 2008, 34:203-222.
147. Cevc G., Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta 1992, 1104:226-232.
148. Blume G., Cevc G., Crommelin M.D., Bakker-Woudenberg I.A., Kluft C., Storm G. Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim. Biophys. Acta 1993, 1149:180-184.
149. Cevc G., Blume G. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, transfersomes. Biochim. Biophys. Acta 2003, 1614:156-164.
150. Cevc G., Schatzlein A., Blume G. Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J. Control. Release 1995, 36:3-16.
151. Touitou E., Godin B., Dayan N., Weiss C., Piliponsky A., Levi-Schaffer F. Intracellular delivery mediated by an ethosomal carrier. Biomaterials 2001, 22:3053-3059.
152. Touitou E., Dayan N., Bergelson L., Godin B., Eliaz M. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control. Release 2000, 65:403-418.
153. Dayan N., Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 2000, 21:1879-1885.
154. Muller R.H., Radtke M., Wissing S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 2002, 54(Suppl. 1):S131-S155.
155. Schafer-Korting M., Mehnert W., Korting H.C. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Deliv. Rev. 2007, 59:427-443.
156. Santos Maia C., Mehnert W., Schaller M., Korting H.C., Gysler A., Haberland A., Schafer-Korting M. Drug targeting by solid lipid nanoparticles for dermal use. J. Drug Target. 2002, 10:489-495.
157. Wissing S.A., Muller R.H. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J. Control. Release 2002, 81:225-233.
158. Lombardi Borgia S., Regehly M., Sivaramakrishnan R., Mehnert W., Korting H.C., Danker K., Roder B., Kramer K.D., Schafer-Korting M. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J. Control. Release 2005, 110:151-163.
159. Moddaresi M., Brown M.B., Zhao Y., Tamburic S., Jones S.A. The role of vehicle-nanoparticle interactions in topical drug delivery. Int. J. Pharm. 2010, 400:176-182.
160. Cross S.E., Innes B., Roberts M.S., Tsuzuki T., Robertson T.A., McCormick P. Human skin penetration of sunscreen nanoparticles: in-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol. Physiol. 2007, 20:148-154.
161. Monteiro-Riviere N.A., Wiench K., Landsiedel R., Schulte S., Inman A.O., Riviere J.E. Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: an in vitro and in vivo study. Toxicol. Sci. 2011, 123:264-280.
162. Ryman-Rasmussen J.P., Riviere J.E., Monteiro-Riviere N.A. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol. Sci. 2006, 91:159-165.
163. Zhang L.W., Yu W.W., Colvin V.L., Monteiro-Riviere N.A. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 2008, 228:200-211.
164. Samberg M.E., Oldenburg S.J., Monteiro-Riviere N.A. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ. Health Perspect. 2010, 118:407-413.
165. Muhammad F., Monteiro-Riviere N.A., Riviere J.E. Comparative in vivo toxicity of topical JP-8 jet fuel and its individual hydrocarbon components: identification of tridecane and tetradecane as key constituents for dermal irritation. Toxicol. Pathol. 2005, 33:258-266.
166. Monteiro-Riviere N.A., Inman A.O., Barlow B.M., Baynes R.E. Dermatotoxicity of cutting fluid mixtures: in vitro and in vivo studies. Cutan. Ocul. Toxicol. 2006, 25:235-247.
167. El Tayar N., Tsai R.S., Testa B., Carrupt P.A., Hansch C., Leo A. Percutaneous penetration of drugs: a quantitative structure-permeability relationship study. J. Pharm. Sci. 1991, 80:744-749.
168. Abraham M.H., Chadha H.S., Mitchell R.C. The factors that influence skin penetration of solutes. J. Pharm. Pharmacol. 1995, 47:8-16.
169. Ghafourian T., Fooladi S. The effect of structural QSAR parameters on skin penetration. Int. J. Pharm. 2001, 217:1-11.
170. Moss G.P., Cronin M.T. Quantitative structure-permeability relationships for percutaneous absorption: reanalysis of steroid data. Int. J. Pharm. 2002, 238:105-109.
171. Potts R.O., Guy R.H. Predicting skin permeability. Pharm. Res. 1992, 9:663-669.
172. Abraham M.H., Chadha H.S., Martins F., Mitchell R.C., Bradbury M.W., Gratton J.A. Hydrogen bonding part 46. A review of the correlation and prediction of transport properties by an LFER method: physicochemical properties, brain penetration and skin permeability. Pestic. Sci. 1999, 55:78-88.
173. Abraham M.H., Martins F. Human skin permeation and partition: general linear free-energy relationship analyses. J. Pharm. Sci. 2004, 93:1508-1523.
174. Riviere J.E., Brooks J.D. Predicting skin permeability from complex chemical mixtures. Toxicol. Appl. Pharmacol. 2005, 208:99-110.
175. Geinoz S., Guy R.H., Testa B., Carrupt P.A. Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a crtical evaluation. Pharm. Res. 2004, 21:83-92.
176. Riviere J.E., Brooks J.D. Prediction of dermal absorption from complex mixtures: incorporation of vehicle effects and interactions into a QSPR framework. SAR QSAR Environ. Res. 2007, 18:31-44.
177. Flynn G.L. Physicochemical determinants of skin absorption. Principles of Route-to-Route Extrapolation for Risk Assessment 1990, 93-127. Elsevier, New York. T.R. Gerrity, C.J. Henry (Eds.).
178. Wilschut A., Berge W.F., Robinson P.J., McKone T.E. Estimating skin permeation. The validation of five mathematical skin permeation models. Chemosphere 1995, 30:1275-1296.
179. Ghafourian T., Samaras E.G., Brooks J.D., Riviere J.E. Validated models for predicting skin penetration from different vehicles. Eur. J. Pharm. Sci. 2010, 41:612-616.
180. Diudea M.V., Gutman I. Weiner-type topological indices. Croat. Chem. Acta 1998, 71:21-51.
181. Riviere J.E., Brooks J.D. Predicting skin permeability from complex chemical mixtures: dependency of quantitative structure permeation relationships on biology of skin model used. Toxicol. Sci. 2011, 119:224-232.
182. Bunge A.L., Cleek R.L. A new method for estimating dermal absorption from chemical mixture exposure. 2. Effect of molecular weight and octanol-water partitioning. Pharm. Res. 1995, 12:88-95.
183. Bunge A.L., Cleek R.L., Vecchia B.E. A new method for estimating dermal absorption from chemical exposure. 3. Compared with steady-state methods for prediction and data analysis. Pharm. Res. 1995, 12:972-982.
184. Riviere J.E. Percutaneous absorption of complex mixtures. Marzulli and Maibach's Dermatotoxicity 2007, 63-70. CRC Press, New York. seventh ed. H. Zhai, K.P. Wilhelm, H.I. Maibach (Eds.).